United Airlines Holdings Inc. UAL,
on Friday began charter flights to receive doses of Pfizer Inc.’s PFE,
and BioNTech SE’s BNTX,
9 vaccine ready for rapid distribution if vaccine candidate approved by regulators, according to a Wall Street Journal report citing people familiar with the matter. Last Friday, Pfizer and BioNTech submitted an application for the vaccine trial’s permit for emergency use, making their vaccine candidate the first in line with U.S. regulators. The companies have said that the vaccine, called BNT162b2, had an efficacy rate of 95% in a late-stage clinical trial. Pfizer has laid the groundwork for moving quickly if it gets approval from the Food and Drug Administration and other regulators around the world, the Wall Street Journal said. The distribution plan includes existing and additional cold storage locations in the United States and Europe in addition to “dozens of cargo flights and hundreds of truck trips each day,” the newspaper said. Shares in Pfizer and United were around 0.1% each in the extended session on Friday.